logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Madrigal Pharmaceuticals Appoints Bill Sibold As Chief Executive Officer My Ches Co

Sep 14, 2023•about 2 years ago

Position

Chief Executive Officer

Company

Madrigal

Bill Sibold
ConshohockenBiotechnologyHealth Care

Description

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. this week announced that Bill Sibold has succeeded Paul Friedman, M.D., as Chief Executive Officer and joined Madrigal’s Board of Directors. Dr

Company Information

Company

Madrigal

Location

Conshohocken, Pennsylvania, United States

About

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months